Greenlight Capital’s Nuvation Bio NUVB Stock Holding History

Greenlight Capital’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$52.8K	Hold	34,995	–	–	﹤0.01%	38
2023 Q3	$46.9K	Hold	34,995	–	–	﹤0.01%	36
2023 Q2	$63K	Hold	34,995	–	–	﹤0.01%	38
2023 Q1	$58.1K	Hold	34,995	–	–	﹤0.01%	36
2022 Q4	$67.2K	Hold	34,995	–	–	﹤0.01%	35
2022 Q3	$78K	Hold	34,995	–	–	0.01%	35
2022 Q2	$113K	Hold	34,995	–	–	0.01%	40
2022 Q1	$184K	Hold	34,995	–	–	0.01%	44
2021 Q4	$297K	Hold	34,995	–	–	0.02%	45
2021 Q3	$348K	Hold	34,995	–	–	0.02%	46
2021 Q2	$326K	Sell	34,995 -115,005	-77%	-$1.31M	0.02%	60
2021 Q1	$1.57M	Sell	150,000 -150,000	-50%	-$1.68M	0.11%	38
2020 Q4	$3.51M	Hold	300,000	–	–	0.21%	30
2020 Q3	$3.36M	Buy	+300,000	New	+$3.24M	0.27%	28

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital's NUVB Position: Q4 2023 in Review

Greenlight Capital held its Nuvation Bio (NUVB) position steady in Q4 2023 at 34,995 shares worth $52.8K. The position accounts for ﹤0.01% of the portfolio, ranked #38.

Greenlight Capital first reported a position in NUVB in Q3 2020 and has held it in 14 quarters since. The position peaked at $3.51M in Q4 2020. 116 funds tracked by Wall St. Rank hold NUVB as of Q4 2023.

Greenlight Capital held 34,995 shares of Nuvation Bio worth $52.8K as of Q4 2023.
Greenlight Capital left its Nuvation Bio share count unchanged in Q4 2023.
Nuvation Bio made up ﹤0.01% of Greenlight Capital's portfolio in Q4 2023, its #38 holding.
Greenlight Capital first reported a position in Nuvation Bio in Q3 2020 and has held it in 14 quarters since.
Greenlight Capital's Nuvation Bio position peaked at $3.51M in Q4 2020.
116 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2023.

Based on Greenlight Capital's 13F filing for Q4 2023, filed 14 Feb 2024.